Department of Neurology, Mayo Clinic, Jacksonville, FL, USA; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA; Department of Neurology, Faculty of Health Science, Medical University of Warsaw, Warsaw, Poland.
Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
Parkinsonism Relat Disord. 2021 May;86:48-51. doi: 10.1016/j.parkreldis.2021.03.026. Epub 2021 Apr 2.
Approximately 10% of patients with Parkinson disease (PD) present with early-onset disease (EOPD), defined as diagnosis before 50 years of age. Genetic factors are known to contribute to EOPD, with most commonly observed mutations in PRKN, PINK1, and DJ1 genes. The aim of our study was to analyze the frequency of PRKN, PINK1, and DJ1 mutations in an EOPD series from 4 neighboring European countries: Czech Republic, Germany, Poland, and Ukraine.
Diagnosis of PD was made based on UK Brain Bank diagnostic criteria in departments experienced in movement disorders (1 from Czech Republic, 1 from Germany, 9 from Poland, and 3 from Ukraine). EOPD was defined as onset at or before 50 years of age. Of the 541 patients recruited to the study, 11 were Czech, 38 German, 476 Polish, and 16 Ukrainian. All cohorts were fully screened with Sanger sequencing for PRKN, PINK1, and DJ1 and multiplex ligation-dependent probe amplification for exon dosage.
PRKN homozygous or double heterozygous mutations were identified in 17 patients: 1 Czech (9.1%), 1 German (2.6%), 14 Polish (2.9%), and 1 Ukrainian (6.3%). PINK1 homozygous mutations were only identified in 3 Polish patients (0.6%). There were no homozygous or compound heterozygous DJ1 mutations in analyzed subpopulations. One novel variant in PRKN was identified in the Ukrainian series.
In the analyzed cohorts, mutations in the genes PRKN, PINK1, and DJ1 are not frequently observed.
大约 10%的帕金森病(PD)患者存在早发性疾病(EOPD),其定义为 50 岁之前诊断。遗传因素已知与 EOPD 有关,最常见的突变发生在 PRKN、PINK1 和 DJ1 基因中。我们研究的目的是分析来自 4 个欧洲邻国(捷克共和国、德国、波兰和乌克兰)的 EOPD 系列中 PRKN、PINK1 和 DJ1 突变的频率。
根据英国脑库诊断标准,在有经验的运动障碍科(1 个来自捷克共和国,1 个来自德国,9 个来自波兰,3 个来自乌克兰)诊断 PD。EOPD 定义为 50 岁或 50 岁以前发病。在招募的 541 名患者中,有 11 名来自捷克,38 名来自德国,476 名来自波兰,16 名来自乌克兰。所有队列均进行了 PRKN、PINK1 和 DJ1 的 Sanger 测序和外显子剂量的多重连接依赖性探针扩增全筛查。
在 17 名患者中发现 PRKN 纯合或双杂合突变:1 名捷克(9.1%)、1 名德国(2.6%)、14 名波兰(2.9%)和 1 名乌克兰(6.3%)。仅在 3 名波兰患者中发现 PINK1 纯合突变(0.6%)。分析亚群中未发现 DJ1 纯合或复合杂合突变。在乌克兰系列中发现了 1 个新的 PRKN 变体。
在所分析的队列中,PRKN、PINK1 和 DJ1 基因的突变并不常见。